Atorvastatin leads sales in Spain, along with drugs fighting diabetes, with healthy and cinfa as laboratories.
Diabetes, cholesterol, hypertension or headaches.The best -selling medications last year in the pharmacy offices have as a common characteristic that some of the most characteristic diseases of developed countries, reflecting the changes in lifestyle and food and aging of the population.
Recipe medicines sales contributed a business of 14,173 million euros to pharmacies last year, 1.7% more.Within this prescription segment, the brand drugs (which are associated with a patent registered by a laboratory, which prevents another from marketing it) barely grew 0.6% in value (attributed mainly to the control of health expenditure),But they continue to represent eight out of ten euros that move in this sales channel and 60% of the units that are dispensed.
Lantus, an injectable insulin indicated to combat diabetes, was the brand medication that contributed the most income to its manufacturer, the Sanofi French, according to data from the IMS Health consultant, taking into account its sales in euros (PVP SELL OUT).This drug raised its income by 8.6% and unbalanced the first position obtained in 2014 to Lyrica de Pfizer, prescribed against anxiety, epilepsy and neuropathic pain.
patent
The American development accused the loss of the patent, defeated in 2015 (which makes the price of a product place at the level of its equivalent in generic).Their sales dropped 48% and foured to fourth position.Lyrica entered pharmacies 276 million euros in 2014, when 4.74 million units were dispensed.
Sanofi, for which Lantus is one of its star drugs (the patent expired last May), places another of its second position, the Clexane antithrombotic, whose sales grew 6%.
In the third position, Spiriva, by Boehringer Ingelheim, against COPD (chronic obstructive pulmonary disease), which scale from the fifth position of 2014, although its sales decreased 6.5% last year.Those of Seretide for asthma, of the British GSK, which is placed in fourth place also.
Faced with the slight rise of the brands, the genericians grew 6.3% last year in value.Seven of the twenty best -selling drugs with a recipe in this segment corresponded to atorvastatin, the active substance prescribed to reduce blood cholesterol.
The first place is for the drug manufactured by the Navarra Cinfa.Its sale increased by 14.1%, although that of its German competitor Stada, which occupies the second position, grew by 19.6% (in 2014 it was the fourth).
The active ingredients of analgesics, gastric protectors, coronary heart disease (Bayer's adiro remains among the best selling, growing almost 6%) and antihypertensives complete the panorama of the best -selling generic people with a recipe in pharmacy in euros.
Health Care
The segment that grows most in pharmacies is that of health care (or self -care), 6.6% in value (5,399 million euros) and 4.3% in units (537 million) in 2015.
Four out of ten euros generated correspond to the OTCs (drugs without recipe as analgesics or antigripales), but the two best -selling articles in value are diapers for urinary incontinence, incopack, in Indas Laboratories, which grew 8.7%, it isLeader in this ranking, followed by Lindor de Ausonia (Procter & Amp; Gamble).
The product that raised its income was voltadol, an anti -inflammatory marketed by Novartis (+148%).
